The following paper has been selected by the Editor for FREE access to all during February and March 2011
Professor Ben Davidson has written a comprehensive review article of the differences and similarities between malignant mesothelioma and ovarian / peritoneal serous carcinoma. Davidson provides valuable insight into current research using molecular biology and flow cytometry, from which new markers will be developed, and concludes: “Cytology performs no worse than surgical pathology and has the additional advantage of being able to provide high-quality fresh material consisting of living cells for molecular analysis within both the diagnostic and research setting.”
Please also read in the same issue the editorial by Professor Sheaff and an original article from Professor Davidson’s group:
Sheaff M. Should cytology be an acceptable means of diagnosing malignant mesothelioma? (editorial) Cytopathology 2011;22(1):3-4.
Yuan Y, Dong HP, Nymoen DA et al. PINCH-2 expression in cancers involving serosal effusions using quantitative PCR. Cytopathology 2011;22(1):22-9.